Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 36 PAGES: 36

More Info
									                Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT
                                       Analysis Review

       Reference Code: GDME7173FSA                                                                                      Publication Date: APR 2011

       1 Corporate Avenue                 Phone            +61 3 92139000                                 Revenue           18 (million AUD)
       Rowville, VIC                      Fax              +61 3 92136490                                 Net Profit        -6.61 (million AUD)
       3149                               Website          www.universalbiosensors.com                    Employees         95
       Australia                          Exchange         UBI [Australian Stock Exchange (Sydney)] Industry                Medical Equipment

      Company Overview
       Universal Biosensors, Inc. (Universal Biosensors) is a medical diagnostics company engaged in the research, development,
       manufacture and commercialization of in vitro diagnostic tests for point of care market. The diagnostic tests consist of a novel
       disposable test strip and a reusable meter. It develops point of care blood tests such as C-reactive protein test, D-dimer test and
       Prothrombin time test. The company uses electrochemical cell technology for the development of point of care tests. Universal
       Biosensors is headquartered in Victoria, Australia.

      Key Executives                                                              SWOT Analysis
                     Name                                  Title                  Universal Biosensors, Inc., SWOT Analysis
       Andrew Denver                        Chairman                              Strengths                     Weaknesses

       Colin Adam, Ph.D.                    Director
                                                                                  Focused Research and                 Low Return on Equity
       Denis Hanley                         Director                              Development Activities
       Andrew Jane                          Director                                                                   Single Manufacturing Facility
                                                                                  Novel Strip and Meter
       Marshall Heinberg                    Director                              Technologies
       Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData

      Share Data
                                                                                  Opportunities                        Threats
       Universal Biosensors, Inc.
                                                                          1.31    Growth in Emerging                   Dependence on Single
                                                                                  Economies                            Customer
       EPS (AUD)                                                            NA

       Market Cap (million AUD)                                             NA    New Product Launches                 Regulatory Clearances
       Enterprise Value (million AUD)                                       NA

       Shares Outstanding (million)                                        159
       Source: Annual Report, Company Website, Primary and Secondary Research,    Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                  GlobalData
       GlobalData

      Financial Performance                                                       Recent Developments
                                                                                  Sep 09, 2010         Universal     Biosensors      Announces
                                                                                                       Retirement Of Mark Morrisson As CEO
                                                                                  Aug 09, 2010         Universal  Biosensors    Reports    Total
                                                                                                       Revenues Of AUD2.76 Million In Q2 2010
                                                                                  Mar 16, 2010         Universal Biosensors Reports Net Profit Of
                                                                                                       AUD1.4 Million In 2009
                                                                                  Jan 28, 2010         LifeScan Launches One Touch Verio In
                                                                                                       Netherlands
                                                                                  Jan 11, 2010         Universal Biosensors Announces Board
        Source: Annual Report, Company Website, Primary and Secondary Research,                        Changes
        GlobalData                                                                Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                  GlobalData




Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis                                                         Reference Code: GDME7173FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
      Table of Contents
      Table of Contents........................................................................................................................................................................................................... 2
      List of Tables .................................................................................................................................................................................................................. 4
      List of Figures................................................................................................................................................................................................................. 4
      Section 1 - About the Company ..................................................................................................................................................................................... 5
      Universal Biosensors, Inc. - Key Facts .......................................................................................................................................................................... 5
      Universal Biosensors, Inc. - Key Employees ................................................................................................................................................................. 6
      Universal Biosensors, Inc. - Key Employee Biographies ............................................................................................................................................... 7
      Universal Biosensors, Inc. - Major Products and Services ............................................................................................................................................ 8
      Universal Biosensors, Inc. - Medical Equipment Pipeline Products Data ...................................................................................................................... 9
            Universal Biosensors, Inc. Pipeline Products by Equipment Type .......................................................................................................................... 9
            Universal Biosensors, Inc. Pipeline Products by Development Stage................................................................................................................... 11
      Universal Biosensors, Inc. - History ............................................................................................................................................................................. 13
      Universal Biosensors, Inc. - Company Statement........................................................................................................................................................ 14
      Universal Biosensors, Inc. - Locations And Subsidiaries ............................................................................................................................................. 15
            Head Office............................................................................................................................................................................................................ 15
      Section 2 – Company Analysis .................................................................................................................................................................................... 16
      Universal Biosensors, Inc. - Business Description....................................................................................................................................................... 16
      Universal Biosensors, Inc. - Corporate Strategy .......................................................................................................................................................... 17
      Universal Biosensors, Inc. - SWOT Analysis ............................................................................................................................................................... 18
            SWOT Analysis - Overview ................................................................................................................................................................................... 18
            Universal Biosensors, Inc. - Strengths................................................................................................................................................................... 18
                  Strength - Focused Research and Development Activities............................................................................................................................. 18
                  Strength - Novel Strip and Meter Technologies .............................................................................................................................................. 18
                  Strength - Strong Liquidity Position................................................................................................................................................................. 18
                  Strength - Expanding Market Share in the Sector........................................................................................................................................... 18
                  Strength - Agreement with LifeScan ............................................................................................................................................................... 19
            Universal Biosensors, Inc. - Weaknesses ............................................................................................................................................................. 19
                  Weakness - Low Return on Equity.................................................................................................................................................................. 19
                  Weakness - Single Manufacturing Facility ...................................................................................................................................................... 19
            Universal Biosensors, Inc. - Opportunities............................................................................................................................................................. 19
                  Opportunity - Growth in Emerging Economies................................................................................................................................................ 19
                  Opportunity - New Product Launches ............................................................................................................................................................. 20
                  Opportunity - Growing Point-of-Care Testing Market...................................................................................................................................... 20
                  Opportunity - Growing Older Population ......................................................................................................................................................... 20
                  Opportunity - Rising Healthcare Expenditure in the US .................................................................................................................................. 20
            Universal Biosensors, Inc. - Threats...................................................................................................................................................................... 21
                  Threat - Dependence on Single Customer...................................................................................................................................................... 21
                  Threat - Regulatory Clearances ...................................................................................................................................................................... 21
                  Threat - Intense Competition........................................................................................................................................................................... 21
      Universal Biosensors, Inc. - Key Competitors.................
								
To top